Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tricaprilin PK and Food Effect Study in Healthy Volunteers
NCT03551769Phase 1Completed
- Sponsor
- Cerecin
- Start
- Aug 2018
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of tricaprilin in Alzheimer's disease (AD) (2 cohorts), sponsored by Cerecin. Primary endpoints: Total ketones PK parameters at 1 day, Beta-hydroxybutyrate PK parameters at 1 day and 1 more. Started Aug 2018; status: completed.
02
Drugs
tricaprilin
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT03551769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03551769.